[Treatment of Takayasu's disease with low-dose methotrexate. Apropos of a case]
Related Experiment Videos
M Alcalay1, F Debiais, I Chartier
1Service de Rhumatologie, CHU Poitiers.
Revue Du Rhumatisme (Ed. Francaise : 1993)
|June 1, 1994
Abstract:
Persistent evidence of inflammation at the occlusive phase of Takayasu's arteritis is of adverse prognostic significance. Low-dose weekly methotrexate therapy given in combination with a corticosteroid may be effective in such patients. We report a personal case which supports the data obtained by Fauci and coworkers, as well as the conclusions of the other two similar case-reports in the literature.